This review focuses on the role and molecular mechanisms of the PI3K/AKT/mTOR signaling pathway in tumor radioresistance, summarizes the progress in research on related inhibitors, and evaluates their potential applications in clinical radiotherapy. The gene discussed is AKT1; the disease is neoplasm.